Resultados de búsqueda - Dubin, Gary

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis por Han, Htay Htay, Karkada, Naveen, Jayadeva, Girish, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy of the HPV-16/18 Vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 Vaccine Trial por Hildesheim, Allan, Wacholder, Sholom, Catteau, Gregory, Struyf, Frank, Dubin, Gary, Herrero, Rolando

Enlace del recurso Enlace del recurso Enlace del recurso

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: A double-blind randomized trial por Leroux-Roels, Geert, Clément, Frédéric, Vandepapelière, Pierre, Fourneau, Marc, Heineman, Thomas, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme por Angelo, Maria-Genalin, David, Marie-Pierre, Zima, Julia, Baril, Laurence, Dubin, Gary, Arellano, Felix, Struyf, Frank

Enlace del recurso Enlace del recurso Enlace del recurso

The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge por Peng, Tao, Ponce-de-Leon, Manuel, Jiang, Hongbin, Dubin, Gary, Lubinski, John M., Eisenberg, Roselyn J., Cohen, Gary H.

Enlace del recurso Enlace del recurso

In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor por Nagashunmugam, Thandavarayan, Lubinski, John, Wang, Liyang, Goldstein, Lester T., Weeks, Benjamin S., Sundaresan, Periasamy, Kang, Eugene H., Dubin, Gary, Friedman, Harvey M.

Enlace del recurso Enlace del recurso

New Concepts for Vaccines por Murphy, Trudy V., Dubin, Gary, Belshe, Robert B., Monath, Thomas P., Glowinski, Irene B., Daniels, Susan A., Gaydos, Joel C.

Enlace del recurso Enlace del recurso

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12–15 years: end-of-study results from a community-randomized study up to 6.5 years por Bi, Dan, Apter, Dan, Eriksson, Tiina, Hokkanen, Mari, Zima, Julia, Damaso, Silvia, Soila, Maaria, Dubin, Gary, Lehtinen, Matti, Struyf, Frank

Enlace del recurso Enlace del recurso Enlace del recurso

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials por Ott, Mary A., Crawley, Francis P., Sáez-Llorens, Xavier, Owusu-Agyei, Seth, Neubauer, David, Dubin, Gary, Poplazarova, Tatjana, Begg, Norman, Rosenthal, Susan L.

Enlace del recurso Enlace del recurso Enlace del recurso

Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix™: Approach and outcome por Dubin, Gary, Toussaint, Jean-François, Cassart, Jean-Pol, Howe, Barbara, Boyce, Donna, Friedland, Leonard, Abu-Elyazeed, Remon, Poncelet, Sylviane, Han, Htay Htay, Debrus, Serge

Enlace del recurso Enlace del recurso Enlace del recurso

Structural and Antigenic Analysis of a Truncated Form of the Herpes Simplex Virus Glycoprotein gH-gL Complex por Peng, Tao, Ponce de Leon, Manuel, Novotny, Michael J., Jiang, Hongbin, Lambris, John D., Dubin, Gary, Spear, Patricia G., Cohen, Gary H., Eisenberg, Roselyn J.

Enlace del recurso Enlace del recurso

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-s... por Einstein, Mark H, Takacs, Peter, Chatterjee, Archana, Sperling, Rhoda S, Chakhtoura, Nahida, Blatter, Mark M, Lalezari, Jacob, David, Marie-Pierre, Lin, Lan, Struyf, Frank, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18–45 years:... por Einstein, Mark H, Levin, Myron J, Chatterjee, Archana, Chakhtoura, Nahida, Takacs, Peter, Catteau, Grégory, Dessy, Francis J, Moris, Philippe, Lin, Lan, Struyf, Frank, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years por Schwarz, Tino F., Huang, Li-Min, Valencia, Alejandra, Panzer, Falko, Chiu, Cheng-Hsun, Decreux, Annabelle, Poncelet, Sylviane, Karkada, Naveen, Folschweiller, Nicolas, Lin, Lan, Dubin, Gary, Struyf, Frank

Enlace del recurso Enlace del recurso Enlace del recurso

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: Follow-up from months 12–24 in a Phase III randomized study of healthy... por Einstein, Mark H, Baron, Mira, Levin, Myron J, Chatterjee, Archana, Fox, Bradley, Scholar, Sofia, Rosen, Jeffrey, Chakhtoura, Nahida, Meric, Dorothée, Dessy, Francis J, Datta, Sanjoy K, Descamps, Dominique, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial por Lehtinen, Matti, Eriksson, Tiina, Apter, Dan, Hokkanen, Mari, Natunen, Kari, Paavonen, Jorma, Pukkala, Eero, Angelo, Maria-Genalin, Zima, Julia, David, Marie-Pierre, Datta, Sanjoy, Bi, Dan, Struyf, Frank, Dubin, Gary

Enlace del recurso Enlace del recurso Enlace del recurso

Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women por Bernstein, David I., Bellamy, Abbie R., Hook, Edward W., Levin, Myron J., Wald, Anna, Ewell, Marian G., Wolff, Peter A., Deal, Carolyn D., Heineman, Thomas C., Dubin, Gary, Belshe, Robert B.

Enlace del recurso Enlace del recurso Enlace del recurso

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied por Vänskä, Simopekka, Luostarinen, Tapio, Baussano, Iacopo, Apter, Dan, Eriksson, Tiina, Natunen, Kari, Nieminen, Pekka, Paavonen, Jorma, Pimenoff, Ville N, Pukkala, Eero, Söderlund-Strand, Anna, Dubin, Gary, Garnett, Geoff, Dillner, Joakim, Lehtinen, Matti

Enlace del recurso Enlace del recurso Enlace del recurso

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials... por Lehtinen, Matti, Lagheden, Camilla, Luostarinen, Tapio, Eriksson, Tiina, Apter, Dan, Harjula, Katja, Kuortti, Marjo, Natunen, Kari, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Siitari-Mattila, Mari, Struyf, Frank, Nieminen, Pekka, Paavonen, Jorma, Dubin, Gary, Dillner, Joakim

Enlace del recurso Enlace del recurso Enlace del recurso

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women por El-Zein, Mariam, Ramanakumar, Agnihotram V., Naud, Paulo, Roteli-Martins, Cecilia M., de Carvalho, Newton S., Colares de Borba, Paola, Teixeira, Julio C., Moscicki, Anna-Barbara, Harper, Diane M., Tyring, Stephen K., Ramjattan, Brian, Dubin, Gary, Franco, Eduardo L.

Enlace del recurso Enlace del recurso Enlace del recurso